Responses
Short Oral Presentation
Short oral presentation session 16: SLE treatment 2
LSO-091 Study design of ENERGY: a phase 2/3 trial to assess the efficacy and safety of nipocalimab in warm autoimmune hemolytic anemia
Compose a Response to This Article
Other responses
No responses have been published for this article.